Renal Dose Adjustment
Hepatic Dose Adjustment
Cautions: Use cautiously in
Pregnancy Category:C
Breastfeeding: Because of the low levels of isoniazid in breastmilk and safe administration directly to infants, it is unlikely to cause adverse reactions in infants, but infants should be monitored for rare instances jaundice. Limited information indicates that rifampin is excreted in breastmilk in low levels and thus would not be expected to adversely affect the breastfed infant. This information is based upon LactMed database (available at http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT). According to the AAP, women with tuberculosis who have been treated for > 2 wks and who are not considered contagious may breastfeed. Rifampin and isoniazid is compatible and considered safe with breastfeeding based upon data from AAP Policy Guidelines (available at http://aappolicy.aappublications.org/cgi/content/full/pediatrics;108/3/776 last accessed 25 February 2011).
Isoniazid
Rifampin
US Trade Name(s)
US Availability
isoniazid/rifampin (generic)
Rifamate
Canadian Trade Name(s)
Canadian Availability
UK Trade Name(s)
UK Availability
Rifinah
Australian Trade Name(s)
Australian Availability
Antimicrobials
Antituberculosis AgentsAntituberculosis Combinations
Infectious Disease
Antituberculosis AgentsAntituberculosis Combinations
Pricing data from www.DrugStore.com in U.S.A.
Warning: This pricing information is subject to change at the sole discretion of DS Pharmacy. For the most current and up-to-date pricing information, please visit drugstore.com.
Drug Name: Rifamate 150 MG-300 MG Oral Capsule
Ingredient(s): Isoniazid mixture with Rifampin
Imprint: RIFAMATE
Color(s): Red
Shape: Capsule
Size (mm): 14.00
Score: 1
Inactive Ingredient(s): colloidal silicon dioxide / fd&c blue no. 1 / fd&c red no. 40 / gelatin / magnesium stearate / sodium starch glycolate / titanium dioxide.
Drug Label Author:
sanofi-aventis U.S. LLC
DEA Schedule:
Non-Scheduled